These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2150476)

  • 21. [Is left ventricular hypertrophy in hypertension a marker for coronary risk factors?].
    Otterstad JE
    Tidsskr Nor Laegeforen; 1993 Feb; 113(5):609-13. PubMed ID: 8465321
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of sympathetic nervous activity on regression of cardiac hypertrophy.
    Strauer BE; Bayer F; Brecht HM; Motz W
    J Hypertens Suppl; 1985 Dec; 3(4):S39-44. PubMed ID: 2937889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypertensive heart disease: the critical role of left ventricular hypertrophy.
    Massie BM; Tubau JF; Szlachcic J; O'Kelly BF
    J Cardiovasc Pharmacol; 1989; 13 Suppl 1():S18-24. PubMed ID: 2468972
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular hypertrophy, arterial hypertension and sudden death.
    Messerli FH
    J Hypertens Suppl; 1990 Dec; 8(7):S181-6. PubMed ID: 2151334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Regulation of coronary circulation in patients with hypertensive cardiopathy: role of ventricular mechanoreceptors].
    De Luca N; Rosiello G; Marcheggiano R; Raponi M; Di Cristinzi I; Condorelli M
    Minerva Med; 1987 Dec; 78(23):1731-8. PubMed ID: 2962011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of chronic ACE inhibition on cardiac hypertrophy and coronary vascular reserve in spontaneously hypertensive rats with developed hypertension.
    Clozel JP; Kuhn H; Hefti F
    J Hypertens; 1989 Apr; 7(4):267-75. PubMed ID: 2524524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathophysiological considerations in left ventricular hypertrophy.
    Frohlich ED
    J Clin Hypertens; 1987 Mar; 3(1):54-65. PubMed ID: 2952767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structural and functional adaptation in the rat myocardium and coronary vascular bed caused by changes in pressure and volume load.
    Friberg P
    Acta Physiol Scand Suppl; 1985; 540():1-47. PubMed ID: 3161269
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Left ventricular hypertrophy and myocardial ischemia in systemic hypertension.
    Dunn FG; Pringle SD
    Am J Cardiol; 1987 Dec; 60(17):19I-22I. PubMed ID: 2961246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormalities in the coronary circulation that occur as a consequence of cardiac hypertrophy.
    Marcus ML; Koyanagi S; Harrison DG; Doty DB; Hiratzka LF; Eastham CL
    Am J Med; 1983 Sep; 75(3A):62-6. PubMed ID: 6226197
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic hypertension, left ventricular hypertrophy and coronary artery disease.
    Tubau JF; Szlachcic J; London MJ; Hollenberg M; Mangano D; Massie BM
    Am J Cardiol; 1987 Dec; 60(17):23I-28I. PubMed ID: 2961247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormalities of the coronary circulation associated with left ventricular hypertrophy.
    O'Gorman DJ; Sheridan DJ
    Clin Sci (Lond); 1991 Dec; 81(6):703-13. PubMed ID: 1662574
    [No Abstract]   [Full Text] [Related]  

  • 34. [Left ventricular hypertrophy. Advantages and disadvantages].
    Cohen Solal A; Jaeger P; Juliard JM; Dahan M; Brusset A; Gourgon R
    Presse Med; 1987 Nov; 16(38):1912-6. PubMed ID: 2962142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical studies on peripheral hemodynamics in arterial hypertension.
    Kato M; Yoshida T; Namekawa G; Saiki S; Suzuki T; Ogino T; Kimura T
    Angiology; 1976; 27(7):422-32. PubMed ID: 162572
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The hypertensive heart: pathogenesis, variants, and prognostic value.
    Yurenev AP; Tkachuk VA; Mazaev AV; Dubov PB; Dyakonova EG; Patrusheva IF; Gerashchenko YS; Nesterova AL; Menshikov MYu ; Atakhanov SE
    Health Psychol; 1988; 7 Suppl():105-11. PubMed ID: 2977326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coronary microvascular disease in hypertensives.
    Lucarini AR; Picano E; Salvetti A
    Clin Exp Hypertens A; 1992; 14(1-2):55-66. PubMed ID: 1541047
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 'Silent ischemia,' ventricular arrhythmias, and complications of hypertension.
    Devereux RB
    Circulation; 1992 May; 85(5):1948-50. PubMed ID: 1533353
    [No Abstract]   [Full Text] [Related]  

  • 39. Hypertension and ischemia: evolving concepts.
    Gradman AH
    J Am Coll Cardiol; 1992 Mar; 19(4):816-7. PubMed ID: 1531992
    [No Abstract]   [Full Text] [Related]  

  • 40. Electrocardiographic left ventricular hypertrophy and risk of coronary heart disease. The Framingham study.
    Kannel WB; Gordon T; Castelli WP; Margolis JR
    Ann Intern Med; 1970 Jun; 72(6):813-22. PubMed ID: 4247338
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.